StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
FLGT

Fulgent Genetics, Inc.

FLGT Nasdaq Services-Medical Laboratories EDGAR ↗
$17.61
-2.60 -12.86%

Key statistics

from XBRL data in SEC filings
Market cap
$485M
Revenue (TTM)
$324M
Net income (TTM)
-$84.4M
EPS (TTM)
$-0.31
P/E ratio
Dividend yield
Free cash flow
-$124M
Cash
$26.3M
Total assets
$1.09B
Gross margin
35.6%
52-week range
$13.46 – $31.04

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 30, 2026 8-K Other events Jun 2, 2026 8-K Other events May 21, 2026 8-K Director or officer change; Shareholder vote results May 14, 2026 10-Q Quarter ended 2026-03-31 May 1, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 1, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Mar 17, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2026 8-K Entered a material agreement; Other events Dec 22, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2025 8-K Other events Oct 20, 2025 10-Q Quarter ended 2025-06-30 Aug 1, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 1, 2025 8-K Shareholder vote results May 15, 2025 10-Q Quarter ended 2025-03-31 May 2, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 2, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 28, 2025 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 8, 2024 10-Q Quarter ended 2024-06-30 Aug 2, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 2, 2024 8-K Shareholder vote results May 16, 2024 10-Q Quarter ended 2024-03-31 May 3, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 3, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 28, 2024 10-Q Quarter ended 2023-09-30 Nov 3, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 3, 2023 10-Q Quarter ended 2023-06-30 Aug 4, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Aug 4, 2023 8-K Director or officer change; Shareholder vote results May 18, 2023 10-Q Quarter ended 2023-03-31 May 5, 2023 8-K Results of operations (earnings release); Regulation FD disclosure May 5, 2023 10-K Fiscal year ended 2022-12-31 Feb 28, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Feb 28, 2023 8-K Entered a material agreement Jan 12, 2023